The effect of collagen tripeptide for patients with atopic dermatitis

The effect of collagen tripeptide for patients with atopic dermatitis - The effect of collagen tripeptide for patients with atopic dermatitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004877

Enrollment

200

Registered

2011-01-14

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

The volunteer with mild-to-moderate atopic dermatitis were given an 4-week treatment with oral collagen tripeptide (4g/day). The volunteer with mild-to-moderate atopic dermatitis were given an 4-week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patients with mild-to-moderate atopic dermatit 2) Male or female subjects (18 to 90 years old)

Exclusion criteria

Exclusion criteria: 1) Under treatment of steroid or cyclosporine A orally 2) Under phototherapy on upper arms

Design outcomes

Primary

Measure	Time frame
trans epidermal water loss(TEWL), stratum corneum hydration and visual analog scale were measured at 2-week intervals for 6 weeks.	—

Countries

Japan

Contacts

Public ContactTomoko Okawa

Yokohama City University Graduate School of Medicine Department of Environmental Immuno-Dermatology

dertom55@yahoo.co.jp045-787-2675

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026